Cyclerion Therapeutics, Inc.

Historical 13F Holders

Symbol
CYCN
CUSIP
23255M105
All holders as of
Q3 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 23255M105 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
MFN Partners Management, LP 13G/A
0% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q3 1 552 $2.00 k
2023 Q2 1 552 $2.00 k
2023 Q1 38 20.6 M $8.95 M
2022 Q4 47 24.3 M $16.0 M
2022 Q3 43 21.3 M $18.3 M
2022 Q2 45 20.9 M $11.5 M
2022 Q1 55 23.1 M $25.6 M
2021 Q4 66 23.7 M $40.7 M
2021 Q3 70 24.7 M $75.8 M
2021 Q2 74 24.6 M $96.0 M
2021 Q1 74 22.4 M $62.5 M
2020 Q4 79 22.0 M $67.2 M
2020 Q3 77 22.9 M $140 M
2020 Q2 77 17.7 M $105 M
2020 Q1 83 18.5 M $49.1 M
2019 Q4 82 15.7 M $42.6 M
2019 Q3 95 19.6 M $237 M
2019 Q2 108 19.6 M $224 M
2019 Q1 5 855 k $12.7 M